Results 141 to 150 of about 2,334 (301)

BRAND VALUATION: A RANKING APPROACH

open access: yesInternational scientific journal "Internauka". Series: "Economic Sciences", 2021
Anzhelika Chepelenko, Sergiy Tserkovnyy
openaire   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

open access: yesMolecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li   +10 more
wiley   +1 more source

Valuation of candidate brand equity dimensions and voting intention: alternative polling data in the Spanish presidential election

open access: gold, 2023
Pablo Gutiérrez Rodríguez   +3 more
openalex   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

open access: yesMolecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff   +11 more
wiley   +1 more source

Framework to identify innovative sources of value creation from platform technologies. [PDF]

open access: yesProc Natl Acad Sci U S A
Jones CH   +7 more
europepmc   +1 more source

Evaluating the Marketing Impact of a Regional Branding Program Using Contingent Valuation Methods: The Case of the Appalachian Grown™ Branding Program

open access: green, 2016
Olumide Aborisade   +11 more
openalex   +1 more source

Brand Valuation of Garment Companies for Tax Purposes

open access: diamond, 2022
Rahmat Heryat Furqon   +3 more
openalex   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Amateurism in flux: NIL beyond borders and the strategic crossroads of European basketball. [PDF]

open access: yesFront Sports Act Living
Bourdas DI   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy